Local Institution - 2120 — Houston, Texas

Local Institution - 2120 is a clinical research site located in Houston, Texas, United States 77030-3721.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 2120 has participated in 1 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation.

Sponsors: Turning Point Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 2120?

Local Institution - 2120 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 2120 conducted?

Local Institution - 2120 has 1 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation.

Is Local Institution - 2120 accredited by Crixeo Health?

Local Institution - 2120 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 2120?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.